1
|
Ranjan A, Mahto SK, Anand N, Barla NPA. Aberrant expression of CD markers in AML in patients attending RIMS, Ranchi - An observational study. J Family Med Prim Care 2024; 13:841-844. [PMID: 38736799 PMCID: PMC11086789 DOI: 10.4103/jfmpc.jfmpc_754_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2023] [Revised: 06/15/2023] [Accepted: 06/16/2023] [Indexed: 05/14/2024] Open
Abstract
Introduction Acute myeloid leukaemia (AML) is a tumour of hematopoietic progenitors caused by acquired oncogenic mutations that impede differentiation, leading to the accumulation of immature myeloid blasts in the marrow. Aberrant phenotype is a phenomenon in which lymphoid-associated and other myeloid lineage markers are expressed in myeloblasts or myeloid-associated markers are expressed in lymphoblasts. Materials and Methods Diagnosed cases of AML were included in this study to study the aberrant expression using multiparametric flow cytometry. Results Out of a sample size of 50, 30 cases expressed aberrant CD markers. Male: Female ratio was 0.76. Majority of cases belonged to the age group >60 years of age. CD 7 was overall the most common aberrant CD marker. Conclusion Immunophenotyping has a significant role in diagnosis and predicting prognosis of hematopoietic malignancies in the absence of more advanced diagnostic tools like cytogenetics.
Collapse
Affiliation(s)
- Amit Ranjan
- Department of Pathology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
| | - Sunil K. Mahto
- Department of Pathology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
| | - Nicky Anand
- Department of Pathology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
| | - Nidhi P. A. Barla
- Department of Pathology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
| |
Collapse
|
2
|
dos Santos MM, dos Santos AS, Santos HHDM, Santos LDS, Nascimento RJM, Torres AJL. Immunophenotypic characterization of acute leukemias in Bahia, Brazil. EINSTEIN-SAO PAULO 2023; 21:eAO0117. [PMID: 36629681 PMCID: PMC9785573 DOI: 10.31744/einstein_journal/2023ao0117] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Accepted: 08/22/2022] [Indexed: 12/24/2022] Open
Abstract
OBJECTIVE To characterize the immunophenotypic profile of acute leukemias in the population of the state of Bahia, Brazil. METHODS This is a descriptive, retrospective study. From 2014 to 2018, 796 new cases of acute leukemia were evaluated. The data were obtained from analysis of reports and records of tests performed by flow cytometry immunophenotyping. All individuals of all age groups diagnosed as acute lymphoblastic leukemia or acute myeloid leukemia were included in the study. Demographic variables and expression of leukemia antigens were evaluated. RESULTS Most cases were diagnosed as acute myeloid leukemia and 42.7% as acute lymphoblastic leukemia. Significant differences were found in expression of markers in acute leukemias when age groups were compared, as well as in demographic characteristics. B-cell acute lymphoblastic leukemia was more prevalent than cases of T-cell origin. Assessing the aberrant markers in acute myeloid leukemias, the non-acute promyelocytic leukemia group presented expression of CD7 and CD56 as the most frequent ones. In B-cell acute lymphoblastic leukemia, the most frequent aberrant markers were CD66c, CD13 and CD33. CONCLUSION Significant differences were found as to several antigens when comparing adults and children, and these findings may contribute to future studies correlating the phenotypic profile to genetic characteristics and therapeutic response, including specific antigen therapies, which may be better targeted.
Collapse
Affiliation(s)
- Mariane Melo dos Santos
- Universidade Federal da BahiaSalvadorBABrazil Universidade Federal da Bahia, Salvador, BA, Brazil.
| | - Allan Souza dos Santos
- Universidade Federal da BahiaSalvadorBABrazil Universidade Federal da Bahia, Salvador, BA, Brazil.
| | | | - Lorene da Silva Santos
- Universidade Federal da BahiaSalvadorBABrazil Universidade Federal da Bahia, Salvador, BA, Brazil.
| | | | - Alex José Leite Torres
- Universidade Federal da BahiaSalvadorBABrazil Universidade Federal da Bahia, Salvador, BA, Brazil.
| |
Collapse
|
3
|
Serin I, Orhan B, Sonmez D, Cinli TA, Goze H, Serin H, Gulesir B, Yokus O. A new approach in acute myeloid leukemia (AML): Samatya-predicting score. Leuk Res Rep 2022; 17:100293. [PMID: 35242525 PMCID: PMC8866886 DOI: 10.1016/j.lrr.2022.100293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2021] [Revised: 01/07/2022] [Accepted: 02/14/2022] [Indexed: 11/28/2022] Open
Abstract
We aimed to examine the efficiency of our new scoring system in non-APL AML cases,. The AUC for the median risk score of 2,5 in ROC analysis was 0,635 (p = 0,006) for exitus; 0,605 (p = 0,024) for being responder,. The sensitivity for mortality was 88%, the specificity 42%, the PPV 90,1%, and the NPV was 24,7%,. In terms of being non-responder to induction therapy, the sensitivity was 90,1%, the specificity 25,3%, the PPV 89,8%, and the NPV was 32%.
We aimed to examine the efficiency for prediction of prognosis and response in non-APL AML cases of the “Samatya-predicting score”. A total of 213 patients diagnosed between January 2010-December 2020 were examined. Of the 158 patients included in the study, the median value of risk score was determined as 2,5. The sensitivity for mortality was 88% and the specificity was 42%. In terms of being non-responder to induction therapy, the sensitivity was 90,1%, the specificity was 25,3%. OS was shorter in those with high risk scores. This study makes an important contribution to the literature in terms of creating a different perspective to predict prognosis in AML.
Collapse
Affiliation(s)
- Istemi Serin
- Department of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Org. Nafiz GURMAN Cad., Samatya, Fatih, Istanbul, Istanbul, 34098 Turkey
- Corresponding author.
| | - Bagnu Orhan
- Department of Medical Biochemistry, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey
| | - Derya Sonmez
- Department of Medical Biochemistry, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey
| | - Tahir Alper Cinli
- Department of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Org. Nafiz GURMAN Cad., Samatya, Fatih, Istanbul, Istanbul, 34098 Turkey
| | - Hasan Goze
- Department of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Org. Nafiz GURMAN Cad., Samatya, Fatih, Istanbul, Istanbul, 34098 Turkey
| | - Huriye Serin
- Department of Medical Biochemistry, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey
| | - Begum Gulesir
- Department of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey
| | - Osman Yokus
- Department of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Org. Nafiz GURMAN Cad., Samatya, Fatih, Istanbul, Istanbul, 34098 Turkey
| |
Collapse
|
4
|
Precursor B-lineage acute lymphoblastic leukemia patients with aberrant natural killer cell and T cell - lineage antigen expression: experience from a tertiary cancer care center. Hematol Transfus Cell Ther 2020; 44:143-150. [PMID: 33526373 PMCID: PMC9123560 DOI: 10.1016/j.htct.2020.08.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Revised: 07/11/2020] [Accepted: 08/06/2020] [Indexed: 11/21/2022] Open
Abstract
Introduction Flow cytometric immunophenotyping (FCI) plays a major role in diagnosing hematologic malignancies. In patients diagnosed with precursor B-lineage acute lymphoblastic leukemia (B-ALL), expression of certain non-lineage/cross lineage antigens is of prognostic and cytogenetic relevance. There is a paucity of studies that have comprehensively analyzed the clinical and laboratory profiles of B-ALL patients showing aberrant T/natural killer (NK) cell antigen expression. Materials and methods This is a prospective study where 152 consecutive B-ALL patients were analyzed for aberrant expression of T/NK cell antigens (CD1a, CD5, CD4, CD7, CD8 and CD56) by FCI. The clinical and laboratory profile of these T/NK-cell antigen-expressing B-ALL patients was statistically analyzed against conventional B-ALL patients. Results In our B-ALL cohort, CD5, CD7 and CD56 expression were observed in one, six and nine patients, respectively. CD56-expressing B-ALL patients were predominantly children (89%) and presented as standard clinical risk (p = 0.010) disease with frequent ETV6-RUNX1 fusion (p = 0.021) positivity. On the contrary, CD7-expressing B-ALL patients were adolescent-young adult/adult-age skewed (83%) and had an adverse cytogenetic profile (p = 0.001), especially for the frequent presence of BCR-ABL1 fusion (p = 0.004) and KMT2A rearrangement (p = 0.045). CD7-expressing B-ALL patients had inferior event-free survival (p = 0.040) than their CD56-expressing counterparts, but there was no significant difference in the overall survival (p = 0.317). Conclusion In comparison to conventional B-ALL patients, there are significant differences in the age, cytogenetic profile and event-free survival of T/NK-cell antigen-expressing B-ALL patients.
Collapse
|
5
|
Pinheiro LHS, Trindade LD, Costa FDO, Silva NDL, Sandes AF, Nunes MAP, Correa CB, Almeida CAC, da Cruz GS, de Lyra Junior DP, Schimieguel DM. Aberrant Phenotypes in Acute Myeloid Leukemia and Its Relationship with Prognosis and Survival: A Systematic Review and Meta-Analysis. Int J Hematol Oncol Stem Cell Res 2020; 14:274-288. [PMID: 33603989 PMCID: PMC7876425 DOI: 10.18502/ijhoscr.v14i4.4484] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2020] [Accepted: 10/14/2020] [Indexed: 01/03/2023] Open
Abstract
Background: The aim of this review was to evaluate the influence of aberrant phenotypes in prognosis and survival in acute myeloid leukemia (AML) patients by multiparametric flow cytometry. Materials and Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a review of PubMed, Scopus, Science Direct and Web of Science was carried out through 1998 to 2016, conducted by two reviewers independently, evaluating titles, abstracts and full-texts of the selected studies. Results: Ten studies were included on this review, in which the aberrant phenotype expression of 17 markers were detected in AML patients. From these, 11 aberrant phenotypes were associated with prognosis, which eight had shown negative impact on prognosis: CD7, CD56, CD15, CD2, CD3, CD90low, CD123high, CD117high, and three others were associated with good prognosis: CD19, CD98high and CD117+/CD15+. Meta-analysis showed that aberrant expression of CD56 as a poor prognostic marker with unfavorable outcomes is implicated in decreased overall survival in AML patients in 28 months (95% CI: 0.62 to 0.92). Conclusion: This was observed when there was association between CD56 expression and other prognostic factors, influencing on patients' management care and treatment.
Collapse
Affiliation(s)
| | - Louise Dantas Trindade
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| | | | - Nathanielly de Lima Silva
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| | - Alex Freire Sandes
- Department of Medicine, Hematology Course, Federal University of São Paulo, São Paulo, São Paulo, Brazil
| | | | - Cristiane Bani Correa
- Department of Morphology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| | | | | | | | - Dulce Marta Schimieguel
- Department of Pharmacy, Laboratory of Hematology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| |
Collapse
|
6
|
Aoki M, Kobayashi K, Taji Y, Shimizu Y, Ohta A, Watanabe A, Fukushima T, Tanaka R, Ebihara Y. Pediatric B-lineage Acute Lymphoblastic Leukemia With CD56 Expression: A Report of 2 Cases. J Pediatr Hematol Oncol 2020; 42:249-250. [PMID: 31876778 DOI: 10.1097/mph.0000000000001704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
| | | | | | - Yuki Shimizu
- Pediatric Hematology/Oncology, Saitama Medical University International Medical Center Saitama, Japan
| | - Atsuhiko Ohta
- Pediatric Hematology/Oncology, Saitama Medical University International Medical Center Saitama, Japan
| | - Atsuko Watanabe
- Pediatric Hematology/Oncology, Saitama Medical University International Medical Center Saitama, Japan
| | - Takashi Fukushima
- Pediatric Hematology/Oncology, Saitama Medical University International Medical Center Saitama, Japan
| | - Ryuhei Tanaka
- Pediatric Hematology/Oncology, Saitama Medical University International Medical Center Saitama, Japan
| | | |
Collapse
|
7
|
Study on the Prognostic Value of Aberrant Antigen in Patients With Acute B Lymphocytic Leukemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 2019; 19:e349-e358. [PMID: 31076372 DOI: 10.1016/j.clml.2019.03.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Revised: 03/05/2019] [Accepted: 03/15/2019] [Indexed: 12/18/2022]
Abstract
BACKGROUND Approximately 30% to 60% of patients with acute B-lymphocytic leukemia (B-ALL) show as refractory or relapsed, which is one of the major causes of death in patients with B-ALL, but the methods of the treatment for relapsed/refractory B-ALL (R/R B-ALL) are limited. The chimeric antigen receptors redirected T cells (CAR-T cells) have showed a strong anti-leukemia role for B-ALL. About 90% of patients with R/R B-ALL treated with CD19-CAR-T cells achieved complete remission. However, 60% to 70% of patients relapsed after CAR-T cells treatment, which may be related to target antigen reduction or escape. New products are urgently needed to prevent and treat antigenic escapes causing recurrence. PATIENTS AND METHODS In this article, we retrospectively analyzed the immunophenotype of patients with B-ALL initially diagnosed in our center from January 2010 to December 2015 to determine whether aberrant antigen expression was associated with the prognosis of patients in order to find new targets for immunotherapy. RESULTS The results show that disease-free and overall survival in patients without aberrant antigen expression were better than patients with aberrant antigen expression. The most common abnormal antigens were CD123, CD13, and CD56. Correlation analysis showed a negative correlation between aberrant CD123 expression and both disease-free and overall survival. CONCLUSION Therefore, in the construction of CAR-T cells in patients with R/R B-ALL, conventional CD19 can be combined with aberrant antigens such as CD123 to form CARs with bi-specific antigens or multi-specific antigens may achieve the purpose of improving efficacy. However, more clinical trials are needed.
Collapse
|
8
|
Basharat M, Khan SA, Din NU, Ahmed D. Immunophenotypic characterisation of morphologically diagnosed cases of Acute Myeloid Leukaemia (AML). Pak J Med Sci 2019; 35:470-476. [PMID: 31086535 PMCID: PMC6500804 DOI: 10.12669/pjms.35.2.614] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
Objective: To determine immunophenotypic pattern in newly diagnosed cases of acute myeloid leukaemia by flow cytometry and its correlation with morphological findings. Methods: This study was conducted at Haematology (Pathology) department, Army Medical College, in collaboration with Immunology Department Armed Forces Institute of Pathology, Rawalpindi from 16 November 2016 to 16 November 2017. One hundred and six patients of both genders and all age groups diagnosed as acute myeloid leukaemia were included in the study. Demographic data was noted. Complete blood counts, bone marrow examination and cytochemical stains were carried out and evaluated microscopically for blast percentage and morphology. Immunophenotyping was performed by flow cytometry using standard panel on peripheral blood or bone marrow samples. The surface and cytoplasmic antigens of interest were analysed and correlated with morphological findings. Results: The most commonly expressed antigens were CD13, CD33, CD45 and HLA-DR. Almost all blasts expressed CD45 with no remarkable difference among the subtypes of AML. The mean positivity for CD13 among all AML subtypes was 57% and for CD33 was 67%. Aberrant expression of CD7 and CD19 were expressed in 26.4% and 1.1% of all cases respectively. There was concordance rate of 90% between morphology and FCM in our study. Conclusion: Flow cytometric analysis of acute leukaemia done by a combination of patterns and intensity of antigen expression improves diagnostic yield in AML. CD13, CD33 and CD45 are the most frequently expressed antigens in AML. Our findings suggest a 90% concordance between morphology and flow cytometry. It is pertinent to conclude that flow cytometry results interpreted with morphology are complementary.
Collapse
Affiliation(s)
- Maria Basharat
- Maria Basharat, MBBS. Pathology Department, Army Medical College, National University of Medical Sciences, Islamabad, Pakistan
| | - Saleem Ahmed Khan
- Saleem Ahmed Khan, MBBS, MCPS, FCPS, FRCP, PhD. Pathology Department, Army Medical College, National University of Medical Sciences, Islamabad, Pakistan
| | - Nasir Ud Din
- Nasir ud din MBBS, FCPS. Pathology Department, Army Medical College, National University of Medical Sciences, Islamabad, Pakistan
| | - Dawood Ahmed
- Dawood Ahmed MBBS, FCPS. Pathology Department, Army Medical College, National University of Medical Sciences, Islamabad, Pakistan
| |
Collapse
|
9
|
Ouyang G, Xu Z, Jiang D, Zhu H, Wang Y, Wu W, Sun Y, Sheng L, Xu K, Lou Y, Mu Q, Zhang Y, Wu N, Cheng J, Duan S. Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia. J Int Med Res 2019; 47:1483-1492. [PMID: 30614357 PMCID: PMC6460589 DOI: 10.1177/0300060518819637] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
OBJECTIVES Acute leukemia (AL) is a highly heterogeneous malignant disease caused by hematopoietic cell abnormalities. Our study investigated the potential for immunophenotyping of leukemic cells via flow cytometry and the clinical usefulness of this approach in treatment of AL. METHODS Bone marrow (BM) specimens were collected to detect antigen expression on hematopoietic cells in pre-treatment samples from patients with AL. In addition, fraction survival curves were calculated using the Kaplan-Meier method to explore the effect of markers on prognosis in AL. RESULTS Expression levels of immunophenotypic markers in patients with acute lymphoblastic leukemia (ALL) were significantly different from those in patients with acute myeloid leukemia (AML). In addition, there was a potential association between the surface marker, cluster of differentiation 2 (CD2), and fraction survival in AML. However, no similar result was found in ALL. Moreover, genetic tests showed greater positive variation of the break point cluster-Abelson tyrosine kinase ( BCR-ABL) fusion gene in samples from patients with ALL than in samples from patients with AML. CONCLUSIONS We have shown a rapid and effective flow cytometry method that enables the identification of immunophenotype in AL. Moreover, CD2 may constitute a predictive marker for prognosis in patients with AML.
Collapse
Affiliation(s)
- Guifang Ouyang
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China.,*These authors contributed equally to this work
| | - Zhijuan Xu
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China.,*These authors contributed equally to this work
| | - Danjie Jiang
- 2 School of Medicine, Ningbo University, Ningbo, Zhejiang, China.,*These authors contributed equally to this work
| | - Huiling Zhu
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China
| | - Yi Wang
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China
| | - Wenmiao Wu
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China
| | - Yongcheng Sun
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China
| | - Lixia Sheng
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China
| | - Kaihong Xu
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China
| | - Yanru Lou
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China
| | - Qitian Mu
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China
| | - Yi Zhang
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China
| | - Ningning Wu
- 1 Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China
| | - Jia Cheng
- 2 School of Medicine, Ningbo University, Ningbo, Zhejiang, China.,a Present address: Zhongshan Hospital, Xiamen University, Xiamen, China
| | - Shiwei Duan
- 2 School of Medicine, Ningbo University, Ningbo, Zhejiang, China
| |
Collapse
|
10
|
Shahni A, Saud M, Siddiqui S, Mukry SN. Expression of aberrant antigens in hematological malignancies: A single center experience. Pak J Med Sci 2018; 34:457-462. [PMID: 29805426 PMCID: PMC5954397 DOI: 10.12669/pjms.342.13996] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Background and Objective Aberrant phenotype is a phenomenon of abnormal expression or loss of expression of cell specific lineage marker not associated with specific cell type. Aberrant phenotype expression due to genetic defects may be associated with unfavorable outcome. It can be used to determine minimal residual disease status. The purpose of the study was to find out the occurrence of aberrant phenotypes in leukemia/lymphoma patients. Methods One milliliter peripheral blood or bone marrow samples were analyzed on FACS Calibur flowcytometer. The cells were lysed and stained following standard protocol. Data was acquired and analyzed by CellQuest-Pro software. The Antigenic expression was rated as positive when the percentage of positive blast cells was ≥ 20%. In that manner, aberrant phenotype was considered positive when 20% of blast cells show expression of markers. Results Of a total 145 cases analyzed, 26 were acute myeloid leukemia, 71 of acute lymphoblastic leukaemia, 48 were of Chronic Lymphoid leukemia on the basis of morphological features and confirmed by flow cytometry. Overall, 19% (28) cases showed aberrant expression of antigens. In 32% (9/28) AML patients, CD5, CD7, CD64dim, CD10, CD117, CD25 and TdT were expressed while in 25% (7/28) ALL patients CD33, CD13, HLA-DR and CD3 were detected. Among chronic leukemia, all aberrant expressions were seen in cases of B-CLL (10/28) only; with CD11c, CD3 and CD10 as the aberrantly expressed markers. Conclusion Variability in aberrant phenotype expression was observed in different types of acute and chronic leukemia patients with no prognostic implications on treatment response.
Collapse
Affiliation(s)
- Aneeta Shahni
- Aneeta Shahni, BS (Clinical Laboratory Sciences). National Institute of Blood Diseases & Bone Marrow Transplantation, ST 2/A Block 17 Gulshan-e-Iqbal KDA Scheme 24, Karachi, Pakistan
| | - Madiha Saud
- Madiha Saud, M.Sc. National Institute of Blood Diseases & Bone Marrow Transplantation, ST 2/A Block 17 Gulshan-e-Iqbal KDA Scheme 24, Karachi, Pakistan
| | - Saima Siddiqui
- Saima Siddiqui, MBBS, FCPS. National Institute of Blood Diseases & Bone Marrow Transplantation, ST 2/A Block 17 Gulshan-e-Iqbal KDA Scheme 24, Karachi, Pakistan
| | - Samina Naz Mukry
- Samina Naz Mukry, Ph.D. National Institute of Blood Diseases & Bone Marrow Transplantation, ST 2/A Block 17 Gulshan-e-Iqbal KDA Scheme 24, Karachi, Pakistan
| |
Collapse
|
11
|
Aref S, Azmy E, El-Bakry K, Ibrahim L, Mabed M. Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients. ACTA ACUST UNITED AC 2017; 23:263-270. [PMID: 29161980 DOI: 10.1080/10245332.2017.1404276] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
BACKGROUND The aim of the study is to determine the prognostic relevance of CD200/ CD56 expression in adult acute lymphoblastic leukemia patients. METHODS The expression of CD200 and CD56 by blast cells was assessed by flow cytometry before the start of chemotherapy in 70 B-ALL patients. RESULTS Positive expression of CD200 was detected in forty-six patients (66%) and CD56 was detected in 7 patients (10%) out of 70 patients, respectively. Only three patients (4.3%) had co-expression for CD200+ and CD56+. Splenomegaly and thrombocytopenia were frequently observed more in CD200+ patients. Increased frequency of CD34+ was associated with CD200+and CD56+ patients. The CD200+ and CD56+ subgroups of B-ALL patients had inferior OS and disease free survival compared to CD 200- and CD 56- patients. CONCLUSIONS CD200+ and/or CD56+ positive expression in B-ALL patients at diagnosis is a poor prognostic biomarker. Identification of CD200+ and CD56+ expression at diagnosis is recommended for a better stratification of adult B-ALL patients.
Collapse
Affiliation(s)
- Salah Aref
- a Hematology Unit, Mansoura University Oncology Center , Mansoura University , Mansoura , Egypt
| | - Emad Azmy
- b Hematology Unit, Internal Medicine Department, Faculty of Medicine , Mansoura University , Mansoura , Egypt
| | - Kadry El-Bakry
- c Physiology, Zoology Department, Faculty of Science , Damietta University , Damietta , Egypt
| | - Lobna Ibrahim
- c Physiology, Zoology Department, Faculty of Science , Damietta University , Damietta , Egypt
| | - Mohamed Mabed
- b Hematology Unit, Internal Medicine Department, Faculty of Medicine , Mansoura University , Mansoura , Egypt
| |
Collapse
|
12
|
Jalal SD, Al-Allawi NAS, Al Doski AAS. Immunophenotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients. Int J Lab Hematol 2017; 39:625-632. [PMID: 28722319 DOI: 10.1111/ijlh.12716] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2016] [Accepted: 06/19/2017] [Indexed: 01/11/2023]
Abstract
INTRODUCTION The identification of aberrancies in leukemia-associated immunophenotype (LAIP) of acute lymphoblastic leukemia (ALL) is quite important in the assessment of minimal residual disease (MRD). This study, the first from Iraq, aimed to assess the frequency and patterns of LAIP among Iraqi patients with ALL, to establish future strategies for evaluating MRD. METHODS A total of 282 newly diagnosed Iraqi ALL cases were analyzed with six-parameter flow cytometry using a panel of 29 monoclonal antibodies. RESULTS Immunological subtyping revealed that 85.5% of cases were B-ALL and the remainder T-ALL. LAIP was detected in 97.1% of B-ALL, and in 26.8% of T-ALL. The asynchronous maturation-associated antigen patterns in B-ALL were CD10strong+ /TdTdim+ , CD38dim+ /CD34+ , CD10dim+ /CD34+ , CD10strong /CD20strong+ , CD20strong+ /CD34+, and CD45dim+ /CD20strong+ in 84.6%, while the cross-lineage myeloid expression was seen in 81.3% and aberrant T-cell antigen expression in 6.2%. For T-ALL, asynchronous maturation-associated antigen patterns included the following: CD1a+ /CD5+ /sCD3+ and CD34+ /sCD3+ in 12.2%. Myeloid and B-cell antigen expression were each identified in 7.3% of T-ALL. No significant differences in LAIP were found between children and adults. CONCLUSION The high rates and the patterns of LAIP particularly in Iraqi B-ALL patients may allow the development of more cost-effective strategies for MRD monitoring.
Collapse
Affiliation(s)
- S D Jalal
- Department of Pathology, College of Medicine, University of Sulaimani, Sulaimani, Iraq
| | - N A S Al-Allawi
- Department of Pathology, College of Medicine, University of Duhok, Duhok, Iraq
| | - A A S Al Doski
- Department of Pathology, College of Medicine, University of Duhok, Duhok, Iraq
| |
Collapse
|
13
|
Pediatric Philadelphia-positive B lymphoblastic leukemia with CD56 expression and L2 morphology: Case report and review of the literature. HUMAN PATHOLOGY: CASE REPORTS 2017. [DOI: 10.1016/j.ehpc.2016.12.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
14
|
Wu S, Yang S, Zhu L, Wang Y, Zhang Y, Zhou J, Li D. Prognosis of Patients With de novo Acute Myeloid Leukemia Resistant to Initial Induction Chemotherapy. Am J Med Sci 2016; 351:473-9. [DOI: 10.1016/j.amjms.2016.02.034] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2015] [Accepted: 12/04/2015] [Indexed: 12/19/2022]
|